These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6879880)
1. Therapeutic efficacy of salvage cystectomy. Do results reflect natural history of bladder cancer? Droller MJ; Walsh PC Urology; 1983 Aug; 22(2):118-22. PubMed ID: 6879880 [TBL] [Abstract][Full Text] [Related]
2. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485 [TBL] [Abstract][Full Text] [Related]
3. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications. Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100 [TBL] [Abstract][Full Text] [Related]
4. Treatment of regionally advanced bladder cancer. An overview. Droller MJ Urol Clin North Am; 1992 Nov; 19(4):685-93. PubMed ID: 1441025 [TBL] [Abstract][Full Text] [Related]
5. [Radical cystectomy in the treatment of bladder cancer always in due time?]. May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301 [TBL] [Abstract][Full Text] [Related]
6. Muscle-invasive bladder tumour: can the bladder be preserved? Sella A BJU Int; 2008 Nov; 102(9):1053-4. PubMed ID: 18715247 [No Abstract] [Full Text] [Related]
7. Radical radiotherapy and salvage cystectomy for T2/3 cancer of the bladder. Blandy JP; Jenkins BJ; Fowler CG; Caulfield M; Badenoch DF; England HR; Hope-Stone HF; Mair GM; Mantell BS; Oliver RT Prog Clin Biol Res; 1988; 260():447-51. PubMed ID: 3129734 [No Abstract] [Full Text] [Related]
9. Management of high-risk non-muscle invasive bladder cancer. Brausi M; Olaru V Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212 [TBL] [Abstract][Full Text] [Related]
10. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. May M; Nitzke T; Helke C; Vogler H; Hoschke B Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377 [TBL] [Abstract][Full Text] [Related]
11. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma. Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737 [TBL] [Abstract][Full Text] [Related]
19. Bladder cancer: natural history, tumor markers, and early detection strategies. Foresman WH; Messing EM Semin Surg Oncol; 1997; 13(5):299-306. PubMed ID: 9259085 [TBL] [Abstract][Full Text] [Related]
20. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. May M; Helke C; Nitzke T; Vogler H; Hoschke B Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]